A peptide therapy evaluation is a comprehensive clinical visit focused on reviewing your symptoms, health history, goals, and relevant laboratory data to determine whether peptide therapy may be appropriate. The evaluation is used to guide safe, personalized treatment planning when indicated.

The evaluation includes assessment and treatment planning. If peptide therapy is clinically appropriate, recommendations and next steps are discussed. Prescriptions or therapies are only initiated following medical review and shared decision-making.

Your provider will review:

• Current symptoms and health concerns

• Medical history and medications

• Prior laboratory results (if available)

• Lifestyle factors impacting recovery and performance

• Goals related to energy, recovery, body composition, cognition, or resilience

Additional labs may be recommended if needed for safe decision-making.

Adults typically 18+ who are experiencing:

• Persistent symptoms despite routine labs appearing “normal”

• Slower recovery, fatigue, or performance decline

• Changes in body composition, strength, or metabolic health

• Interest in a medically supervised, targeted approach to optimization

Final candidacy is determined during the evaluation.

When prescribed and monitored by a qualified medical provider, peptide therapy is generally well tolerated. Safety depends on proper patient selection, dosing, monitoring, and follow-up. Peptide therapy is not appropriate for everyone.

No. Peptides are short chains of amino acids that act as signaling molecules in the body. While some peptides influence hormone pathways, peptide therapy is distinct from traditional hormone replacement therapy.

Most peptide therapy evaluations last about 15-30 minutes, allowing adequate time for clinical review, education, and treatment planning. Your health care provider will spend additional time reviewing your medical intake and preparing a protocol individualized to needs.

The peptide therapy evaluation is $169. This includes clinical evaluation, symptom review, and personalized treatment planning when appropriate. Laboratory testing, therapies, and peptides are billed separately if recommended.

Peptide therapy evaluations and treatments are typically considered elective and are not covered by insurance. Intercoastal Health offers transparent, self-pay pricing.

Yes. Peptide therapy may be prescribed in Florida when clinically appropriate and managed by licensed medical providers in accordance with state and federal regulations.

Yes. Peptide therapy evaluations may be offered via telemedicine for Florida residents when clinically appropriate and permitted by regulation. In office evaluation are also available.

If peptide therapy is appropriate:

• A personalized plan is reviewed

• Monitoring and follow-up recommendations are outlined

• Adjustments are made based on response and goals

If peptide therapy is not appropriate, alternative strategies may be discussed.

Longevity medicine programs are highly individualized. Care plans are developed using a patient’s clinical history, lifestyle factors, laboratory data, and response to prior interventions. At Intercoastal Health, programs are continuously adjusted based on objective outcomes and evolving needs, ensuring that recommendations remain aligned with each patient’s health status and long-term goals.

Intercoastal Health serves patients in Jacksonville and surrounding Northeast Florida communities, including Ponte Vedra, Nocatee, St. Johns, Orange Park, and Fleming Island. Patients seeking medically supervised peptide therapy from nearby areas are welcome.

Additionally, we offer telehealth appointments for patients throughout the State of Florida.

If you’re searching for peptide therapy near you in Jacksonville, Florida, Intercoastal Health offers medical provider–led peptide therapy as part of a comprehensive evaluation-based care model. Our clinic serves patients throughout Jacksonville and surrounding Northeast Florida communities and focuses on personalized, medically supervised treatment rather than one-size-fits-all protocols.